Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GEN Restaurant (GENK) Gains from Investment Securities (2022 - 2025)

Historic Gains from Investment Securities for GEN Restaurant (GENK) over the last 4 years, with Q3 2025 value amounting to $533000.0.

  • GEN Restaurant's Gains from Investment Securities fell 8488.37% to $533000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $22.8 million, marking a year-over-year decrease of 3016.89%. This contributed to the annual value of $39.2 million for FY2024, which is 19374.02% up from last year.
  • As of Q3 2025, GEN Restaurant's Gains from Investment Securities stood at $533000.0, which was down 8488.37% from $12.8 million recorded in Q2 2025.
  • Over the past 5 years, GEN Restaurant's Gains from Investment Securities peaked at $23.4 million during Q1 2024, and registered a low of -$11.5 million during Q4 2022.
  • Moreover, its 4-year median value for Gains from Investment Securities was $3.5 million (2024), whereas its average is $5.1 million.
  • As far as peak fluctuations go, GEN Restaurant's Gains from Investment Securities soared by 4582352.94% in 2024, and later plummeted by 9617.01% in 2025.
  • GEN Restaurant's Gains from Investment Securities (Quarter) stood at -$11.5 million in 2022, then soared by 116.67% to $1.9 million in 2023, then skyrocketed by 343.17% to $8.5 million in 2024, then plummeted by 93.75% to $533000.0 in 2025.
  • Its Gains from Investment Securities stands at $533000.0 for Q3 2025, versus $12.8 million for Q2 2025 and $897000.0 for Q1 2025.